Vitreous fluid of db/db mice exhibits alterations in angiogenic and metabolic factors consistent with early diabetic retinopathy

Ophthalmic Research

Volumn 40, Issue 1, 2007, Pages 5-9

  Cohen, Margo P ^a,b   Hud, Elizabeth ^a   Shea, Elizabeth ^a   Shearman, Clyde W ^a  

^a Glycadia Inc   (United States)

^b NONE   (United States)

Author keywords

Diabetes; Pigment epithelium derived factor; Retinopathy; Vascular endothelial growth factor; Vitreous

Indexed keywords

ANGIOGENIC FACTOR; LIPID PEROXIDE; PIGMENT EPITHELIUM DERIVED FACTOR; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; HYPERGLYCEMIA; IMMUNOASSAY; INSULIN RESISTANCE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RETINA BLOOD VESSEL; VITREOUS BODY; WESTERN BLOTTING;

ANGIOGENESIS MODULATING AGENTS; ANIMALS; BLOTTING, WESTERN; COLLAGEN TYPE IV; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; EYE PROTEINS; IMMUNOASSAY; LIPID PEROXIDES; MALE; MICE; NERVE GROWTH FACTORS; OSMOLAR CONCENTRATION; SERPINS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 37349098832     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111151     Document Type: Article

References (27)

1. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Path 1995;146:1029-1039.
2. Ferrara N, Gerber HP, LeCouter P: The biology of VEGF and its receptors. Nat Med 2003;9:669-676.
3. Aiello LP, Bursell SE, Clermont A, et al: Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by orally effective beta-isoform-selective inhibitor. Diabetes 1997;46:1473-1480.
4. Aiello LP, Avery RL, Arrigg PG, et al: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-1487.
5. Dawson DW, Volpert OV, Gillis P, et al: Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999;285:245-258.
6. Bouck N: PEDF: anti-angiogenic guardian of ocular function. Trends Molec Med 2002;8:330-334.
7. Stellmach V, Crawford SE, Zhou W, Bouck N: Prevention of ischemia-induced retinopathy by the natural ocular anti-angiogenic pigment epithelium-derived factor. Proc Natl Acad Sci 2001;98:2593-2597.
8. Mori K, Duh E, Gehlbach P, et al: Pigment epithelium-derived factor inhibits retinal and choroidal vascularization. J Cell Physiol 2001;188:253-263.
9. Moravski CJ, Skinner SL, Stubbs AJ, et al: The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies. Am J Pathol 2003;162:151-160.
10. Gao G, Li Y, Zhang D, Crosson C, Ma J-X: Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett 2001;480:270-276.
11. Gao G, Li Y, Gee S, et al: Down-regulation of VEGF and upregulation of PEDF: a possible mechanism for the anti-angiogenic activity of plasminogen kringle 5. J Biol Chem 2002;277:9492-9497.
12. Ogata N, Nishikawa M, Nishimura T, Mitsuma Y, Matsumura M: Unbalanced vitreous levels of pigment epithelium derived factor and vascular endothelial growth factor in diabetic retinopathy. Am J Ophthalmol 2002;134:348-353.
13. Duh EJ, Yang HS, Haller JA, et al: Vitreous levels of pigment epithelium derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. Am J Ophthalmol 2004;137:668-674.
14. Liu H, Ren JG, Cooper WL, Hawkins CE, Cowan MR, Tong PY: Identification of the anti-vasopermeability effect of pigment epithelium-derived factor and its active site. Proc Natl Acad Sci 2004;101:6605-6610.
15. Boehm BO, Lang G, Feldmann B, et al: Proliferative diabetic retinopathy is associated with a low level of the natural ocular antiangiogenic agent pigment epithelium derived factor (PEDF) in aqueous humor. A pilot study. Horm Metab Res 2003;35:382-386.
16. Boehm BO, Lang G, Volpert O, et al: Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy. Diabetologia 2003;46:394-400.
17. Amin RH, Frank RN, Kennedy A, Elliott D, Puklin JE, Abrams GW: Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1997;38:36-47.
18. Lutty GA, McLeod DS, Merges C, Diggs A, Plouet J: Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol 1996;114:971-977.
19. Clements RS, Robison WG, Cohen MP: Antiglycated albumin therapy ameliorates retinal microvascular pathology in db/db mice. J Diabetes Complications 1998;12:28-33.
20. Midena E, Segato R, Radin S, et al: Studies on the retina of the diabetic db/db mouse. 1. Endothelial cell-pericyte ratio. Ophthalmic Res 1989;21:106-111.
21. Hummel KP, Dica MM, Coleman DL: Diabetes, a new mutant in the mouse. Science 1966;153:1127-1128.
22. Coleman DL, Hummel KP: Hyperinsulinemia in pre-weanling diabetic mice. Diabetologia 1974;1:607-610.
23. Chick WL, Like AA: Studies in the diabetic mutant mouse. Physiological factors associated with alterations in beta cell proliferation. Diabetologia 1970;6:243-251.
24. Augustin AJ, Breipohl W, Boker T, Lutz J, Spitznas M: Increased lipid peroxide levels and myeloperoxidase activity the vitreous of patients suffering from proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 1993;231:647-650.
25. Kotajima N, Kanda, T, Yuuki N, et al: Type IV collagen serum and vitreous fluid levels in patients with diabetic retinopathy. J Int Med Res 2001;29:292-296.
26. Hammes H-P, Lin J, Bretzel RG, Brownlee M, Brier G: Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes 1998;4:401-406.
27. Cheung AKH, Fung MKL, Lo ACY, et al: Aldose reductase deficiency prevents diabetes-induced blood retinal barrier breakdown, apoptosis and glial reactivation in the retina of db/db mice. Diabetes 2005;54:3119-3124.